Prospective Randomized Evaluation of Periureteral Botulinum Toxin Type A Injection for Ureteral Stent Pain Reduction

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 598-602

  Gupta, Mantu ^a   Patel, Trushar ^a   Xavier, Keith ^a   Maruffo, Franzo ^a   Lehman, Daniel ^a   Walsh, Rhonda ^a   Landman, Jaime ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

botulinum toxins; pain; stents; ureter

Indexed keywords

BOTULINUM TOXIN A; OXYCODONE; PARACETAMOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URETER OBSTRUCTION; URETER STENT; URETEROSCOPY;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STENTS; URETER; YOUNG ADULT;

EID: 73749083442     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.10.021     Document Type: Article

References (25)

1. Simpson L.L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 212 (1980) 16
2. Schurch B., Schmid D.M., and Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342 (2000) 665
3. Schulte-Baukloh H., Michael T., Sturzebecher B., et al. Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44 (2003) 139
4. Scott A.B., Kennedy R.A., and Stubbs H.A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103 (1985) 347
5. Smith C.P., Radziszewski P., Borkowski A., et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology 64 (2004) 871
6. Pollard S.G., and Macfarlane R. Symptoms arising from Double-J ureteral stents. J Urol 139 (1988) 37
7. Duvdevani M., Chew B.H., and Denstedt J.D. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 16 (2006) 77
8. Joshi H.B., Stainthorpe A., MacDonagh R.P., et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169 (2003) 1065
9. Beddingfield R., Pedro R.N., Hinck B., et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181 (2009) 170
10. Irani J., Siquier J., Pires C., et al. Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int 84 (1999) 276
11. Chew B.H., Knudsen B.E., and Denstedt J.D. The use of stents in contemporary urology. Curr Opin Urol 14 (2004) 111
12. Damiano R., Autorino R., De Sio M., et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22 (2008) 651
13. Dickson E., and Shevky R. Studies on manner in which the toxin of clostridium botulinum acts upon the body. J Exp Med 37 (1923) 711
14. Carpenter F.G. Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats. J Physiol 188 (1967) 1
15. Schurch B., de Seze M., Denys P., et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174 (2005) 196
16. Joshi H.B., Okeke A., Newns N., et al. Characterization of urinary symptoms in patients with ureteral stents. Urology 59 (2002) 511
17. Al-Kandari A.M., Al-Shaiji T.F., Shaaban H., et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol 21 (2007) 698
18. Breau R.H., and Norman R.W. Optimal prevention and management of proximal ureteral stent migration and remigration. J Urol 166 (2001) 890
19. Pilcher J.M., and Patel U. Choosing the correct length of ureteric stent: a formula based on the patient's height compared with direct ureteric measurement. Clin Radiol 57 (2002) 59
20. Lennon G.M., Thornhill J.A., Sweeney P.A., et al. 'Firm' versus 'soft' double pigtail ureteric stents: a randomised blind comparative trial. Eur Urol 28 (1995) 1
21. Lennon G.M., Thornhill J.A., Grainger R., et al. Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility. Eur Urol 31 (1997) 24
22. Joshi H.B., Chitale S.V., Nagarajan M., et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol 174 (2005) 2303
23. Cui M., Khanijou S., Rubino J., et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107 (2004) 125
24. Ishikawa H., Mitsui Y., Yoshitomi T., et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 44 (2000) 106
25. Durham P.L., and Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44 (2004) 35